WilliamYParkMD

PubMed

• 5 citations
  Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
  Sumathi Sivapalasingam, David J Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner, Romana Hosain, Adnan Mahmood, Angeliki Giannelou, Selin Somersan-Karakaya, Meagan...> ;Clinical Infectious Diseases. 2022 Aug 24
• 61 citations
  Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19.
  Arribas, J., Bhagani, S., Lobo, S., Khaertynova, I., Mateu, L., Fishchuk, R., Park, W., Hussein, K., Kim, S., Ghosn, J., Brown, M., Zhang, Y., Gao, W., Assaid, C., Gro...> ;NEJM Evidence. 2022 Feb 1
• Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity.
  Wurfel, M.M., Park, W.Y., Radella, F., Ruzinski, J., Sandstrom, A., Strout, J., Bumgarner, R.E., Martin, T.R.> ;J Immunol. 2005 Aug 15
• 19 citations
  High and Low Inflammatory Response Phenotypes in 101 Normal Human Subjects
  William Y. Park, Charles W. Frevert, Venus A. Wong, Thomas R. Martin> ;Chest. 2002 Mar 1
• Join now to see all